BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 6.28% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.33% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 4.24% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.83% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.60% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.59% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 3.29% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 3.25% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.24% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 3.20% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 2.92% |
| AZN | AstraZeneca PLC ADR | Healthcare | Drug Manufacturers - General | 2.80% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 2.69% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 2.69% |
| SRT3 | Sartorius Aktiengesellschaft | Healthcare | Medical Instruments & Supplies | 2.45% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.38% |
| CDNS | Cadence Design Systems Inc | Technology | Software - Application | 2.35% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 1.92% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 1.81% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 1.79% |